Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

View the BIG 100 largest medical device companies in the world listings here

Dexcom logo

Dexcom

Rank: 49
2020 Rank: 57

Headquarters: San Diego

2021 Revenues ($USD) : $1,926,700,000
2021 R&D spend : $359,900,000
2021 Number of Employees : 5,500
Fiscal Year End : 12/31/2020
Key People : Kevin Sayer, chair, president andCEO; Donald Abbey, EVP, quality and regulatory affairs; Andrew Balo, EVP, regulatory strategy, clinical affairs and strategic partnership development; Paulu Flynn, EVP, global revenue; Jake Leach, EVP, chief technology officer; Patrick Murphy, EVP, chief legal officer; Steven Pacelli, EVP and managing director, Dexcom Ventures; Chad Patterson, EVP, global marketing; Barry Regan, EVP, global operations; Shelly Selvaraj, SVP, information technology; Sumi Shrishrimal, SVP, chief risk officer; Sadie Stern, EVP, chief human resources officer; Jereme Sylvain, EVP, CFO.

About the company: One of the industry leaders in continuous glucose monitoring for diabetes management, San Diego-based Dexcom was founded in 1999. Its first approved CGM, a three-day sensor, received an FDA nod in 2006 and the company has continued to develop since. Its first G-series CGM, the G4, was approved in 2014. The latest version to hit the market — the wearable G6 sensor — offers a one-touch applicator for the sleek sensor, which is compatible with smart devices that display real-time glucose data. CEO Kevin Sayer announced in late October that the next-generation G7 system is expected to launch in Europe in the fall while the company is on track to submit for FDA clearance soon. –SW
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech